Fred Alger Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.05M | Buy |
+16,752
| New | +$1.17M | ﹤0.01% | 352 |
|
|
2025
Q3 | – | Sell |
-51,644
| Closed | -$4.51M | – | 465 |
|
|
2025
Q2 | $4.51M | Buy |
51,644
+21,128
| +69% | +$1.66M | 0.02% | 243 |
|
|
2025
Q1 | $2.08M | Buy |
+30,516
| New | +$2.49M | 0.01% | 296 |
|
|
2024
Q4 | – | Sell |
-35,182
| Closed | -$2.36M | – | 427 |
|
|
2024
Q3 | $2.36M | Sell |
35,182
-459,462
| -93% | -$37.7M | 0.01% | 315 |
|
|
2024
Q2 | $56.1M | Sell |
494,644
-43,934
| -8% | -$5.55M | 0.27% | 65 |
|
|
2024
Q1 | $74.7M | Sell |
538,578
-479,869
| -47% | -$60.3M | 0.37% | 63 |
|
|
2023
Q4 | $126M | Buy |
1,018,447
+227,090
| +29% | +$23.2M | 0.68% | 31 |
|
|
2023
Q3 | $73.8M | Buy |
791,357
+86,478
| +12% | +$9.75M | 0.42% | 63 |
|
|
2023
Q2 | $90.6M | Buy |
704,879
+114,127
| +19% | +$13.8M | 0.46% | 61 |
|
|
2023
Q1 | $68.6M | Buy |
590,752
+365,035
| +162% | +$40.9M | 0.37% | 84 |
|
|
2022
Q4 | $25.6M | Buy |
225,717
+166,596
| +282% | +$18.3M | 0.14% | 149 |
|
|
2022
Q3 | $4.76M | Sell |
59,121
-15,316
| -21% | -$1.3M | 0.02% | 268 |
|
|
2022
Q2 | $5.55M | Sell |
74,437
-1,016,787
| -93% | -$92.8M | 0.03% | 253 |
|
|
2022
Q1 | $140M | Sell |
1,091,224
-204,388
| -16% | -$22.4M | 0.45% | 63 |
|
|
2021
Q4 | $174M | Sell |
1,295,612
-99,184
| -7% | -$14.3M | 0.44% | 72 |
|
|
2021
Q3 | $191M | Sell |
1,394,796
-130,320
| -9% | -$16.4M | 0.45% | 74 |
|
|
2021
Q2 | $163M | Sell |
1,525,116
-109,984
| -7% | -$10.6M | 0.38% | 93 |
|
|
2021
Q1 | $147M | Buy |
1,635,100
+75,292
| +5% | +$7.07M | 0.38% | 88 |
|
|
2020
Q4 | $144M | Sell |
1,559,808
-212,012
| -12% | -$18.9M | 0.38% | 86 |
|
|
2020
Q3 | $183M | Sell |
1,771,820
-148,260
| -8% | -$15.5M | 0.53% | 51 |
|
|
2020
Q2 | $195M | Sell |
1,920,080
-572,544
| -23% | -$51.2M | 0.64% | 37 |
|
|
2020
Q1 | $168M | Sell |
2,492,624
-516,200
| -17% | -$32.1M | 0.74% | 31 |
|
|
2019
Q4 | $165M | Buy |
3,008,824
+1,199,016
| +66% | +$56.9M | 0.61% | 39 |
|
|
2019
Q3 | $67.5M | Buy |
1,809,808
+616,352
| +52% | +$23.9M | 0.27% | 97 |
|
|
2019
Q2 | $44.7M | Sell |
1,193,456
-394,112
| -25% | -$12.4M | 0.17% | 122 |
|
|
2019
Q1 | $47.3M | Sell |
1,587,568
-310,320
| -16% | -$10.9M | 0.19% | 117 |
|
|
2018
Q4 | $56.8M | Sell |
1,897,888
-728,048
| -28% | -$23.1M | 0.26% | 87 |
|
|
2018
Q3 | $93.9M | Buy |
2,625,936
+77,816
| +3% | +$2.41M | 0.35% | 64 |
|
|
2018
Q2 | $60.5M | Sell |
2,548,120
-846,220
| -25% | -$17.9M | 0.25% | 79 |
|
|
2018
Q1 | $62.9M | Buy |
3,394,340
+2,237,700
| +193% | +$33.1M | 0.29% | 71 |
|
|
2017
Q4 | $16.6M | Buy |
1,156,640
+731,108
| +172% | +$9.5M | 0.07% | 157 |
|
|
2017
Q3 | $5.21M | Sell |
425,532
-7,646,932
| -95% | -$135M | 0.02% | 219 |
|
|
2017
Q2 | $148M | Buy |
8,072,464
+2,781,936
| +53% | +$51.4M | 0.71% | 34 |
|
|
2017
Q1 | $112M | Sell |
5,290,528
-4,587,400
| -46% | -$89.5M | 0.56% | 46 |
|
|
2016
Q4 | $147M | Buy |
9,877,928
+3,244,248
| +49% | +$57.5M | 0.8% | 33 |
|
|
2016
Q3 | $145M | Buy |
6,633,680
+595,292
| +10% | +$13.2M | 0.75% | 32 |
|
|
2016
Q2 | $120M | Buy |
6,038,388
+1,383,660
| +30% | +$23.6M | 0.63% | 36 |
|
|
2016
Q1 | $79M | Buy |
4,654,728
+414,060
| +10% | +$6.92M | 0.4% | 65 |
|
|
2015
Q4 | $86.8M | Buy |
4,240,668
+2,078,204
| +96% | +$43.2M | 0.42% | 66 |
|
|
2015
Q3 | $46.4M | Sell |
2,162,464
-803,308
| -27% | -$17.9M | 0.25% | 89 |
|
|
2015
Q2 | $59.3M | Buy |
2,965,772
+1,707,052
| +136% | +$30M | 0.27% | 97 |
|
|
2015
Q1 | $19.6M | Buy |
+1,258,720
| New | +$19M | 0.09% | 171 |
|
Other funds holding DXCM
VCM
VPM
Fred Alger Management's DXCM Position: Q1 2026 in Review
Fred Alger Management opened a new position in DexCom (DXCM) in Q1 2026: 16,752 shares worth $1.05M. The stake represents ﹤0.01% of the portfolio and ranks #352 among its holdings. This is a return to the name: Fred Alger Management previously reported a position in DXCM as recently as Q2 2025.
Fred Alger Management first reported a position in DXCM in Q1 2015 and has held it in 42 quarters since. The position peaked at $195M in Q2 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Fred Alger Management held 16,752 shares of DexCom worth $1.05M as of Q1 2026.
- DexCom was a new Fred Alger Management position in Q1 2026.
- DexCom made up ﹤0.01% of Fred Alger Management's portfolio in Q1 2026, its #352 holding.
- Fred Alger Management first reported a position in DexCom in Q1 2015 and has held it in 42 quarters since.
- Fred Alger Management's DexCom position peaked at $195M in Q2 2020.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.